Moneycontrol PRO

Gopichand Hinduja expects oil to be at $40-50 once coronavirus crisis is over

The Hinduja Group operates in various industries including automotive, oil and speciality chemicals as well as banking and finance. It runs private sector lender IndusInd Bank in India.

April 29, 2020 / 09:13 AM IST
  • bselive
  • nselive
Todays L/H

Gopichand Hinduja, co-chairman of the Hinduja Group, expects oil prices to remain under pressure but sees them returning to $40-50 a barrel once the economic situation stabilises.

In an interview with CNBC, the India-born British billionaire said weakness in oil prices may persist due to lack of consumption and warehousing woes.

"I don’t think oil prices are going to change from where they are because the consumption is not there, and the warehousing is not there," he said. "Keeping all this in mind, no sooner that things get settled down, I think the oil prices will go back in the range of $40 to $50."

The Hinduja Group operates in various industries including automotive, oil, and speciality chemicals as well as banking and finance. It runs private sector lender IndusInd Bank in India.

Gopichand, who along with his brother Srichand, is considered one of the wealthiest men in the UK felt that the sharp decline in oil began once Saudi Arabia and Russia failed to reach an agreement on a production cut in early March, but the coronavirus pandemic "made it worse because of no demand."


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

The global shutdown of businesses in the wake of the coronavirus pandemic has wiped off nearly a third (nearly 10 million bpd) of the world's oil demand. While the OPEC and Russia did agree to production cuts earlier in April it was not enough to cushion the unprecedented fall-off in demand.

The price on the futures contract for West Texas Intermediate (WTI) fell 13 percent to $11.11 per barrel, recovering from a low of 25 percent. Meanwhile, Brent crude traded down 4.4 percent at $19.11 per barrel.
Moneycontrol News
first published: Apr 29, 2020 09:13 am
ISO 27001 - BSI Assurance Mark